Overall survival in patients with BRAF-mutant melanoma receiving encorafenib plus binimetinib versus vemurafenib or encorafenib (COLUMBUS): a multicentre, open-label, randomised, phase 3 trial
| Image |  |
|---|---|
| Description | scientific article published on 12 September 2018 |
| Author/s |
author: Laure A Moutouh-de Parseval Mario Mandala Ana Arance Paolo Antonio Ascierto Ralf Gutzmer Vanna Chiarion Sileni Caroline Dutriaux Helen Gogas Carmen Loquai Reinhard Dummer Keith Flaherty Claus Garbe Gabriella Liszkay Dirk Schadendorf |
| Publication date | September 12, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |